Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Neuroimmunology

• Publication date

  2010-02-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jneuroim.2009.11.009PMID 20089316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis.

  2009cited by this paper
• C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE

  2009cited by this paper
• Pilot Study of Minocycline in Relapsing-Remitting Multiple Sclerosis

  2008cited by this paper
• Mycobacterium bovis Bacille Calmette-Guérin Infection in the CNS Suppresses Experimental Autoimmune Encephalomyelitis and Th17 Responses in an IFN-γ-Independent Manner1

  2008cited by this paper
• Minocycline Down-regulates MHC II Expression in Microglia and Macrophages through Inhibition of IRF-1 and Protein Kinase C (PKC)α/βII*

  2007cited by this paper
• Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.

  2007cited by this paper
• Minocycline attenuates nitric oxide-mediated neuronal and axonal destruction in vitro.

  2004cited by this paper
• Minocycline reduces gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis

  2004cited by this paper
• Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

  2002cited by this paper
• Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.

  2002influential reference
• Inhibition of autoimmune encephalomyelitis by a tetracycline

  2002cited by this paper
• Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

  2001cited by this paper
• Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.

  1998cited by this paper
• The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors.

  1996cited by this paper
• EncephalomyelitisDevelopment of Experimental Autoimmune IL-17 Plays an Important Role in the

  year unknowncited by this paper

• The role of MMPs and TIMPs in regenerative medicine: From pathological ECM remodeling to therapeutic applications.

  2025cites this paper
• From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment

  2023cites this paper
• Minocycline Alleviates White Matter Injury following Intracerebral Hemorrhage by Regulating CD4+ T Cell Differentiation via Notch1 Signaling Pathway

  2022cites this paper
• Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis

  2021cites this paper
• Immunomodulatory role of the extracellular matrix protein tenascin-C in neuroinflammation.

  2019cites this paper
• Adhesion of T cells to endothelial cells facilitates blinatumomab-associated neurologic adverse events.

  2019cites this paper
• Microglia and CNS Interleukin-1: Beyond Immunological Concepts

  2018cites this paper
• Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis

  2017cites this paper
• Minocycline added to subcutaneous interferon β‐1a in multiple sclerosis: randomized RECYCLINE study

  2016cites this paper
• Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis

  2016cites this paper
• Distinct origins, gene expression and function of microglia and monocyte-derived macrophages in CNS myelin injury and regeneration.

  2016cites this paper
• Exploring the Role of Inflammatory Cytokines in the Pathophysiology, Cognitive Dysfunction and Treatment of Bipolar Disorder: Integrative Evidence Provided by a Proof-of-Concept Study with Adjunctive Minocycline

  2016cites this paper
• Bioinformatics analyses reveal age-specific neuroimmune modulation as a target for treatment of high ethanol drinking.

  2014cites this paper
• Rôles et caractérisation de la microglie dans le développement du néocortex somatosensoriel de la souris

  2014cites this paper
• Paradoxical effects of minocycline in the developing mouse somatosensory cortex

  2014cites this paper
• Antibiotics acting as neuroprotectants via mechanisms independent of their anti-infective activities.

  2013cites this paper
• A Novel Concept of Treatment in MS: Targeting Both Oligodendrocyte Death and Inflammatory Processes by Inhibiting Poly(Adp-Ribose) Polymerase

  2013cites this paper
• Minocycline suppresses experimental autoimmune encephalomyelitis by increasing tissue inhibitors of metalloproteinases

  2013cites this paper
• Effects of Current Medical Therapies on Reparative and Neuroprotective Functions in Multiple Sclerosis

  2013cites this paper
• Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice

  2013cites this paper
• Mechanisms of disease progression

  2013cites this paper
• Is minocycline useful for therapy of acute viral encephalitis?

  2012cites this paper
• Minocycline effects on the cerebrospinal fluid proteome of experimental autoimmune encephalomyelitis rats.

  2012cites this paper
• Staphylococcus aureus harbouring Enterotoxin A as a possible risk factor for multiple sclerosis exacerbations

  2011influential citation
• Role of Primed Microglia in the Aging Brain in Prolonged Sickness and Depressive Behavior Concomitant with Peripheral Immune Stimulation

  2011cites this paper
• CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy

  2011cites this paper
• Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.

  2011cites this paper
• The prospects of minocycline in multiple sclerosis.

  2011cites this paper
• Current Status of the Immunomodulation and Immunomediated Therapeutic Strategies for Multiple Sclerosis

  2011cites this paper
• Probiotic helminth administration in relapsing–remitting multiple sclerosis: a phase 1 study

  2011cites this paper
• Minocycline reduces ethanol drinking.

  2011cites this paper
• 11C-(R)-PK11195 PET Imaging of Microglial Activation and Response to Minocycline in Zymosan-Treated Rats

  2011cites this paper
• Minocycline Suppresses Activation of Nuclear Factor of Activated T Cells 1 (NFAT1) in Human CD4+ T Cells*

  2011cites this paper
• Combination of methylprednisolone and minocycline synergistically improves experimental autoimmune encephalomyelitis in C57 BL/6 mice.

  2010cites this paper
• Prospects for minocycline neuroprotection.

  2010cites this paper
• Minocycline Recovers MTT-Formazan Exocytosis Impaired by Amyloid Beta Peptide

  2010cites this paper